Mechanistic remodeling and immunoregulatory functions of the B cell–humoral immunity axis in inflammatory bowel disease - Takeaways - MDSpire

Mechanistic remodeling and immunoregulatory functions of the B cell–humoral immunity axis in inflammatory bowel disease

  • By

  • Tao Zhang

  • Zhetan Ren

  • Hongkun Zhang

  • Zhengchao Pan

  • Meng Chen

  • Siyuan Bu

  • Xiaozhen Cheng

  • Jirun Peng

  • Yongduo Yu

  • July 9, 2026

  • 0 min

Share

  • 1

    Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation due to immune dysregulation.

  • 2

    B cells contribute to IBD pathogenesis through differentiation, antibody production, and local immune regulation.

  • 3

    Antibodies produced by B cells can modulate inflammation and tissue injury via various immune mechanisms.

  • 4

    The intestinal microenvironment influences B cell activation and antibody output, impacting local immune processes.

  • 5

    Emerging therapeutic strategies targeting B cell and humoral immunity aim to enhance treatment efficacy in IBD.

Original Source(s)

Mechanistic remodeling and immunoregulatory functions of the B cell–humoral immunity axis in inflammatory bowel disease

  • by Tao Zhang, Zhetan Ren, Hongkun Zhang, Zhengchao Pan, Meng Chen, Siyuan Bu, Xiaozhen Cheng, Jirun Peng, Yongduo Yu

  • July 9, 2026

Related Content

Association between OLD and IBD: a systematic review and meta-analysis

Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases

Tracheobronchial stenosis as a rare extraintestinal manifestation of ulcerativecolitis: a case series with different therapeutic approaches